| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12K | — | -96.5% |
| Cost of Revenue | $3K | — | -84.4% |
| Gross Profit | $10K | — | -97.2% |
| R&D Expense | $611K | — | +55.2% |
| SG&A Expense | $2.4M | — | +291.2% |
| Operating Income | -$4.1M | — | -136.1% |
| Pre-tax Income | -$4.5M | — | -247.6% |
| Net Income | -$4.5M | — | -247.6% |
| EPS (Basic) | -$0.15 | — | -36.4% |
| EPS (Diluted) | -$0.15 | — | -36.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $102K | -97.2% | — |
| Inventory | $2.3M | +62.4% | — |
| Current Assets | $3.7M | -42.5% | — |
| Total Assets | $7.8M | -27.3% | — |
| Current Liabilities | $9.5M | +17.0% | — |
| Total Liabilities | $11.9M | +13.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $94K | — | +105.4% |
| Investing Cash Flow | -$278K | — | +0.0% |
| Financing Cash Flow | -$106K | — | -106.5% |
| Stockholders' Equity | -$4.1M | -1809.0% | +84.0% |